Two serious and challenging medical complications associated with volatile substance misuse: Sudden sniffing death and fetal solvent syndrome

Substance Use and Misuse

Volumn 46, Issue SUPPL. 1, 2011, Pages 68-72

  Bowen, Scott E ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

adolescents; fetal solvent syndrome; Sudden sniffing death; toluene; volatile substance misuse

Indexed keywords

VOLATILE ORGANIC COMPOUND;

ADOLESCENT; CHEMICALLY INDUCED DISORDER; FEMALE; FETUS DISEASE; HUMAN; INHALANT ABUSE; MALE; MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ADOLESCENT; FEMALE; FETAL DISEASES; HUMANS; INHALANT ABUSE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; VOLATILE ORGANIC COMPOUNDS;

EID: 79957586986     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.580220     Document Type: Article

References (40)

1. Adgey, A. A., Johnston, P.W.,&McMechan, S. (1995). Sudden cardiac death and substance abuse. Resuscitation, 29(3), 219-221.
2. Anderson, C. E., & Loomis, G. A. (2003). Recognition and prevention of inhalant abuse. American Family Physician, 68(5), 869-874.
3. Anderson, H. R., Dick, B., Macnair, R. S., Palmer, J. C., & Ramsey, J. D. (1982). An investigation of 140 deaths associated with volatile substance abuse in the United Kingdom (1971-1981). Human Toxicology, 1(3), 207-221. (Pubitemid 13226930)
4. Anderson, H. R., Macnair, R. S., & Ramsey, J. D. (1985). Deaths from abuse of volatile substances: A national epidemiological study. British Medical Journal (Clinical Research Education), 290(6464), 304-307. (Pubitemid 15124142)
5. Arai, H., Yamada, M., Miyake, S., Yamashita, S., Iwamoto, H., Aida, N., et al. (1997). Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome. No To Hattatsu, 29(5), 361-366. (Pubitemid 27387731)
6. Arnold, G. L., Kirby, R. S., Langendoerfer, S., &Wilkins-Haug, L. (1994). Toluene embryopathy: Clinical delineation and developmental follow-up. Pediatrics, 93(2), 216-220. (Pubitemid 24047156)
7. Beasley, M., Frampton, L., & Fountain, J. (2006). Inhalant abuse in New Zealand. New Zealand Medical Journal, 119(1233), U1952.
8. Bowen, S. E., Batis, J. C., Paez-Martinez, N., & Cruz, S. L. (2006). The last decade of solvent research in animal models of abuse: Mechanistic and behavioral studies. Neurotoxicology and Teratology, 28(6), 636-647. (Pubitemid 44829925)
9. Bowen, S. E., Daniel, J., & Balster, R. L. (1999). Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug and Alcohol Dependence, 53(3), 239-245. (Pubitemid 29027994)
10. Bukowski, J. A. (2001). Review of the epidemiological evidence relating toluene to reproductive outcomes. Regulatory Toxicology and Pharmacology, 33(2), 147-156. (Pubitemid 32466679)
11. Evans, E. B., & Balster, R. L. (1991). CNS depressant effects of volatile organic solvents. Neuroscience & Biobehavioral Reviews, 15(2), 233-241.
12. Flanagan, R. J., & Ives, R. J. (1994). Volatile substance abuse. Bulletin on Narcotics, 46(2), 49-78.
13. Garriott, J. C. (1992). Death among inhalant abusers. National Institute on Drug Abuse Research Monograph 129. In C. Sharp, F. Beauvais, & R. Spence (Eds.), Inhalant abuse: A volatile research agenda (DHHS Publication No. 93-3475, pp. 181-191). Rockville, MD: National Institute on Drug Abuse. (Pubitemid 23095670)
14. Garriott, J., & Petty, C. S. (1980). Death from inhalant abuse: Toxicological and pathological evaluation of 34 cases. Clinical Toxicology, 16(3), 305-315. (Pubitemid 10021120)
15. Goodwin, T.M. (1988). Toluene abuse and renal tubular acidosis in pregnancy. Obstetrics & Gynecology, 71(5), 715-718.
16. Goodwin, J. M., Geil, C., Grodner, B., & Metrick, S. (1981). Inhalant abuse, pregnancy, and neglected children. American Journal of Psychiatry, 138(8), 1126.
17. Hahn, T., Avella, J., & Lehrer, M. (2006). A motor vehicle accident fatality involving the inhalation of 1,1-difluoroethane. Journal of Analytical Toxicology, 30(8), 638-642. (Pubitemid 44600860)
18. Hannigan, J. H., & Bowen, S. E. (2010). Reproductive toxicology and teratology of abused toluene. Systems Biology in Reproductive Medicine, 56(2), 184-200.
19. Hersh, J. H. (1989). Toluene embryopathy: Two new cases. Journal of Medical Genetics, 26(5), 333-337. (Pubitemid 19117737)
20. Hersh, J. H., Podruch, P. E., Rogers, G., & Weisskopf, B. (1985). Toluene embryopathy. Journal of Pediatrics, 106(6), 922-927. (Pubitemid 15006637)
21. Hunter, A. G., Thompson, D., & Evans, J. A. (1979). Is there a fetal gasoline syndrome? Teratology, 20(1), 75-79.
22. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2010). Monitoring the future national survey results on drug use, 1975-2009: Volume I, secondary school students (NIH Publication No. 10-7584). Bethesda, MD: National Institute on Drug Abuse.
23. Jones, H. E., & Balster, R. L. (1998). Inhalant abuse in pregnancy. Obstetrics and Gynecology Clinics of North America, 25(1), 153-167. (Pubitemid 28141706)
24. Kringsholm, B. (1980). Sniffing-associated deaths in Denmark. Forensic Science International, 15(3), 215-225. (Pubitemid 10064530)
25. Kuczkowski, K. M. (2007). The effects of drug abuse on pregnancy. Current Opinion in Obstetrics & Gynecology, 19(6), 578-585. (Pubitemid 350135442)
26. Maxwell, J. C. (2001). Deaths related to the inhalation of volatile substances in Texas: 1988-1998. American Journal of Drug and Alcohol Abuse, 27(4), 689-697. (Pubitemid 33064017)
27. Meadows, R., & Verghese, A. (1996). Medical complications of glue sniffing. South Medical Journal, 89(5), 455-462. (Pubitemid 26142541)
28. Medina-Mora, M. E., & Real, T. (2008). Epidemiology of inhalant use. Current Opinion in Psychiatry, 21(3), 247-251. (Pubitemid 351489343)
29. NIDA. (1994). Pregnancy and health. Rockville, MD: US Department of Health and Human Services, National Institute on Drug Abuse.
30. NIPC. (2010, June 9). Guidelines for medical examiners, coroners and pathologists: Determining inhalant deaths. Retrieved July 26, 2010, from www.inhalants.org
31. Pearson, M. A., Hoyme, H. E., Seaver, L. H., & Rimsza, M. E. (1994). Toluene embryopathy: Delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics, 93(2), 211-215. (Pubitemid 24047155)
32. SAMHSA. (2007). The NSDUH report: Patterns and trends in inhalant use by adolescent males and females, 2002-2005.
33. Scheeres, J. J., & Chudley, A. E. (2002). Solvent abuse in pregnancy: A perinatal perspective. Journal of Obstetrics and Gynaecology Canada, 24(1), 22-26.
34. Schloneger, M., Stull, A., & Singer, J. I. (2009). Inhalant abuse: A case of hemoptysis associated with halogenated hydrocarbons abuse. Pediatric Emergency Care, 25(11), 754-757.
35. Shepherd, R. T. (1989).Mechanism of sudden death associated with volatile substance abuse. Human Toxicology, 8(4), 287-291.
36. Tenenbein, M., Casiro, O. G., Seshia, M. M., & Debooy, V. D. (1996). Neonatal withdrawal from maternal volatile substance abuse. Archives of Disease in Childhood Fetal Neonatal Education, 74(3), F204-F207.
37. Toutant, C., & Lippmann, S. (1979). Fetal solvents syndrome. Lancet, 1(8130), 1356. (Pubitemid 9203102)
38. Wick, R., Gilbert, J. D., Felgate, P., & Byard, R. W. (2007). Inhalant deaths in South Australia: A 20-year retrospective autopsy study. American Journal of Forensic Medicine and Pathology, 28(4), 319-322. (Pubitemid 350190874)
39. Wilkins-Haug, L., & Gabow, P. A. (1991). Toluene abuse during pregnancy: Obstetric complications and perinatal outcomes. Obstetrics & Gynecology, 77(4), 504-509.
40. Williams, J. F., & Storck, M. (2007). Inhalant abuse. Pediatrics, 119(5), 1009-1017. (Pubitemid 46715675)